Amphiphilic sugar derivatives, formed by condensation of functionalized aliphatic chains with aldoses, form liquid crystals, in most cases smectic. A puzzling observation was the failure of the S,S-acetals of 6-deoxy sugars, L-rhamnose and D-fucose, to form such phases. A satisfactory model to explain this behavior involves-in most cases-the formation of columns, which are destabilized with the deoxy sugars in which the apolar end methyl groups are pushed together.Despite the abundance of chiral centers in the mono-and disaccharides used the smectic phases themselves in general display no chirality. By appropriate molecular design in which the amphiphilic character was deliberately suppressed it was possible to prepare glucose derivatives that exhibit chiral nematic phases as well as impressive helical twisting powers. Simple condensation chemistry is used to produce such derivatives.The amphiphilic character can be deliberately enhanced, and this is readily achieved in double headed 'gemini' derivatives formed by condensation of glucose or lactose with a long chain diamine followed by reduction followed by acylation of the nitrogen atoms with long chain acyl anhydrides. The thermodynamics of micellization of precursors to these derivatives have been studied. The gemini derivatives themselves display remarkable properties including the formation of giant vesicles and an appreciable capacity for the solubilization of hydrocarbons.
Reliable method for the synthesis of aryl β-D-glucopyranosides, using boron trifluoride-diethyl ether as catalyst Smits, Elly; Engberts, Jan; Kellogg, Richard M.; Doren, Henk A. van Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum. Stereospecific formation of aryl 2,3,4,6-tetra-O-acetyl-β β-D-glucopyranosides was achieved by reaction of penta-O-acetyl-β β-D-glucose 1 with substituted phenols in the presence of boron trifluoride. Yields of the purified products varied from 52-85%. Benzyl alcohol could also be glucosylated using similar conditions. All products were purified by crystallization from ethanol. The purity and the anomeric configuration of the products were determined by means of 1 H and 13 C NMR spectroscopy, melting points and optical rotation.
A synthetic route for the preparation of glucosylceramide synthase inhibitor N-[5-(adamantan-1-yl-methoxy)-pentyl]-1-deoxynojirimycin methanesulfonic acid salt (AMP-DNM) has been developed. Herein we report the development and optimization of this synthetic route from its initial version in an academic research laboratory at milligram-scale to the final optimized route that was implemented in a cGMP miniplant on kilogram-scale. The definitive route starts with the separate synthesis of building blocks 2,3,4,6-tetra-O-benzyl-1-deoxynojirimycin and 5-(adamantan-1-yl-methoxy)-pentanal. The aldehyde was synthesized from 1,5-pentanediol in five steps and 45% overall yield. Protected 1-deoxynojirimycin was prepared by a successive hemiacetal reduction/Swern oxidation/double reductive amination sequence of 2,3,4,5-tetra-O-benzyl-d-glucopyranose in 52% overall yield. Reductive amination of the two building blocks produced the benzyl-protected penultimate that was isolated as its crystalline (+)DTTA salt in 68% yield. Hydrogenolysis of the penultimate and crystallization of the end product as its methanesulfonic acid salt produced AMP-DNM in 76% yield with a purity of >99.5%. The described route enables the production of multikilogram amounts of inhibitor AMP-DNM as a stable crystalline solid with high purity under cGMP control.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.